Advertisement
U.S. Markets open in 1 hr 2 mins
S&P Futures
5,874.25 -22.00 (-0.37%) Dow Futures
43,044.00 -133.00 (-0.31%) Nasdaq Futures
20,432.75 -86.75 (-0.42%) Russell 2000 Futures
2,244.70 -10.80 (-0.48%) Crude Oil
71.18 +0.62 (+0.88%) Gold
2,748.50 +9.60 (+0.35%)
Ipca Laboratories Limited (IPCALAB.NS)
NSE - NSE Real Time Price. Currency in INR
Follow
At close: 03:29PM IST
Currency in INR
Valuation Measures4
| Market Cap (intraday) | 409.36B |
| Enterprise Value | 415.29B |
| Trailing P/E | 71.02 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.04 |
| Price/Book (mrq) | 6.47 |
| Enterprise Value/Revenue | 5.11 |
| Enterprise Value/EBITDA | 29.71 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.25 |
| 52-Week Change 3 | N/A |
| S&P500 52-Week Change 3 | N/A |
| 52 Week High 3 | 1,708.65 |
| 52 Week Low 3 | 960.00 |
| 50-Day Moving Average 3 | 1,469.94 |
| 200-Day Moving Average 3 | 1,287.23 |
Share Statistics
| Avg Vol (3 month) 3 | 511.07k |
| Avg Vol (10 day) 3 | 751.11k |
| Shares Outstanding 5 | 253.7M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 135.44M |
| % Held by Insiders 1 | 46.32% |
| % Held by Institutions 1 | 42.43% |
| Shares Short 4 | N/A |
| Short Ratio 4 | N/A |
| Short % of Float 4 | N/A |
| Short % of Shares Outstanding 4 | N/A |
| Shares Short (prior month ) 4 | N/A |
Dividends & Splits
| Forward Annual Dividend Rate 4 | 2 |
| Forward Annual Dividend Yield 4 | 0.12% |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | 0.39 |
| Payout Ratio 4 | 8.80% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | Aug 06, 2024 |
| Last Split Factor 2 | 2:1 |
| Last Split Date 3 | Jan 10, 2022 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Mar 31, 2024 |
| Most Recent Quarter (mrq) | Jun 30, 2024 |
Profitability
| Profit Margin | 7.02% |
| Operating Margin (ttm) | 14.04% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 82.13B |
| Revenue Per Share (ttm) | 323.73 |
| Quarterly Revenue Growth (yoy) | 31.80% |
| Gross Profit (ttm) | N/A |
| EBITDA | 13.42B |
| Net Income Avi to Common (ttm) | 5.77B |
| Diluted EPS (ttm) | 22.76 |
| Quarterly Earnings Growth (yoy) | 18.10% |
Balance Sheet
| Total Cash (mrq) | 8.54B |
| Total Cash Per Share (mrq) | 33.67 |
| Total Debt (mrq) | 14.38B |
| Total Debt/Equity (mrq) | 18.61 |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 249.59 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.